SOX10 and neoplasm: We generated two compounds, OPN-9652 and OPN-9643, that inhibit TEADs, resensitize SOX10 KO cells to BRAFi + MEKi, and delay the onset of tumor resistance to BRAFi + MEKi from MRD.